Literature DB >> 23495214

Foreskin-isolated keratinocytes provide successful extemporaneous autologous paediatric skin grafts.

Jiad N Mcheik1,2, Christine Barrault3, Nathalie Pedretti3, Julien Garnier3, Franck Juchaux3, Guillaume Levard1, Franck Morel2, Jean-Claude Lecron2,4, François-Xavier Bernard2,3.   

Abstract

Severe burns in children are conventionally treated with split-thickness skin autografts or epidermal sheets. However, neither early complete healing nor quality of epithelialization is satisfactory. An alternative approach is to graft isolated keratinocytes. We evaluated paediatric foreskin and auricular skin as donor sources, autologous keratinocyte transplantation, and compared the graft efficiency to the in vitro capacities of isolated keratinocytes to divide and reconstitute epidermal tissue. Keratinocytes were isolated from surgical samples by enzymatic digestion. Living cell recovery, in vitro proliferation and epidermal reconstruction capacities were evaluated. Differentiation status was analysed, using qRT-PCR and immunolabelling. Eleven children were grafted with foreskin-derived (boys) or auricular (girls) keratinocyte suspensions dripped onto deep severe burns. The aesthetic and functional quality of epithelialization was monitored in a standardized way. Foreskin keratinocyte graft in male children provides for the re-epithelialization of partial deep severe burns and accelerates wound healing, thus allowing successful wound closure, and improves the quality of scars. In accordance, in vitro studies have revealed a high yield of living keratinocyte recovery from foreskin and their potential in terms of regeneration and differentiation. We report a successful method for grafting paediatric males presenting large severe burns through direct spreading of autologous foreskin keratinocytes. This alternative method is easy to implement, improves the quality of skin and minimizes associated donor site morbidity. In vitro studies have highlighted the potential of foreskin tissue for graft applications and could help in tissue selection with the prospect of grafting burns for girls.
Copyright © 2013 John Wiley & Sons, Ltd.

Entities:  

Keywords:  burns; differentiation; foreskin; graft; keratinocytes; proliferation

Mesh:

Substances:

Year:  2013        PMID: 23495214     DOI: 10.1002/term.1690

Source DB:  PubMed          Journal:  J Tissue Eng Regen Med        ISSN: 1932-6254            Impact factor:   3.963


  7 in total

Review 1.  Tissue-engineered skin substitutes: an overview.

Authors:  Enrico Catalano; Andrea Cochis; Elena Varoni; Lia Rimondini; Barbara Azzimonti
Journal:  J Artif Organs       Date:  2013-10-05       Impact factor: 1.731

Review 2.  Epidermal Stem Cells in Skin Wound Healing.

Authors:  Yuanyuan Li; Jamie Zhang; Jiping Yue; Xuewen Gou; Xiaoyang Wu
Journal:  Adv Wound Care (New Rochelle)       Date:  2017-09-01       Impact factor: 4.730

Review 3.  Epidermal healing in burns: autologous keratinocyte transplantation as a standard procedure: update and perspective.

Authors:  Jiad N Mcheik; Christine Barrault; Guillaume Levard; Franck Morel; François-Xavier Bernard; Jean-Claude Lecron
Journal:  Plast Reconstr Surg Glob Open       Date:  2014-10-07

Review 4.  Cell therapy for severe burn wound healing.

Authors:  Zhe Li; Peter Maitz
Journal:  Burns Trauma       Date:  2018-05-28

5.  4-Aminopyridine Induces Nerve Growth Factor to Improve Skin Wound Healing and Tissue Regeneration.

Authors:  Mashanipalya G Jagadeeshaprasad; Prem Kumar Govindappa; Amanda M Nelson; Mark D Noble; John C Elfar
Journal:  Biomedicines       Date:  2022-07-08

Review 6.  Alteration of skin properties with autologous dermal fibroblasts.

Authors:  Rajesh L Thangapazham; Thomas N Darling; Jon Meyerle
Journal:  Int J Mol Sci       Date:  2014-05-13       Impact factor: 5.923

Review 7.  Bioactive Molecules for Skin Repair and Regeneration: Progress and Perspectives.

Authors:  Deyun Chen; Qian Hou; Lingzhi Zhong; Yali Zhao; Meirong Li; Xiaobing Fu
Journal:  Stem Cells Int       Date:  2019-12-31       Impact factor: 5.443

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.